Trial Profile
The Efficacy and Tolerability of Highly Selective Beta-1 Agent in Hypertensive Black Patients Residing in Sub Saharan Africa: A Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 17 Aug 2021 Status changed from recruiting to completed.
- 03 Aug 2018 New trial record